The Quantum X bio from Nanoscribe has been undergoing testing in our iL cleanroom for a good six months. The "Kickoff User Meeting" has now taken place. Dr. Simon Binder, who played a key role in the initial trials of the Nanoscribe system and developed the access concept during his time at the Karlsruhe Institute of Technology (KIT), was a guest. He recently took over the management of his own scientific working group at the University of Freiburg and works at the BrainLinks-BrainTools center there.
Such a Quantum-X user meeting will now take place every three months, either in person or in a hybrid format. The main aim is for users who work with 3D printers from NanoScribe to regularly share their experiences. The operation of the Quantum X bio, which is characterized by its lightning-fast precision, sensitive applications in the biotech sector and its flexible use of biocompatible materials, is also to be continuously improved and ultimately the efficiency of use increased. These meetings also offer the opportunity to refine and optimize the usage protocol that has been in place since the start of the test phase.